Sugar Maple Asset Management, LLC Aquestive Therapeutics, Inc. Transaction History
Sugar Maple Asset Management, LLC
- $118 Million
- Q1 2025
A detailed history of Sugar Maple Asset Management, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Sugar Maple Asset Management, LLC holds 29,500 shares of AQST stock, worth $89,090. This represents 0.08% of its overall portfolio holdings.
Number of Shares
29,500Holding current value
$89,090% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding AQST
# of Institutions
122Shares Held
43.1MCall Options Held
504KPut Options Held
148K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$29.6 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$13.1 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.63MShares$7.94 Million1.54% of portfolio
-
Franklin Resources Inc San Mateo, CA2.13MShares$6.45 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $161M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...